Iovance Biotherapeutics Announces Clinical Data Updates for Lifileucel in Advanced Melanoma During American Association for Cancer Research (AACR) 2021 Annual Meeting Read more about Iovance Biotherapeutics Announces Clinical Data Updates for Lifileucel in Advanced Melanoma During American Association for Cancer Research (AACR) 2021 Annual Meeting Iovance Biotherapeutics Appoints Igor Bilinsky as Chief Operating Officer Read more about Iovance Biotherapeutics Appoints Igor Bilinsky as Chief Operating Officer Iovance Biotherapeutics to Present Updated Clinical Data for Tumor Infiltrating Lymphocyte (TIL) Therapy Lifileucel in Advanced Melanoma at American Association for Cancer Research (AACR) 2021 Annual Meeting Read more about Iovance Biotherapeutics to Present Updated Clinical Data for Tumor Infiltrating Lymphocyte (TIL) Therapy Lifileucel in Advanced Melanoma at American Association for Cancer Research (AACR) 2021 Annual Meeting Iovance Biotherapeutics to Present at Upcoming Healthcare Conferences Read more about Iovance Biotherapeutics to Present at Upcoming Healthcare Conferences Iovance Biotherapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Corporate Updates Read more about Iovance Biotherapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Corporate Updates Iovance Biotherapeutics to Host Fourth Quarter and Full Year 2020 Financial Results Conference Call and Webcast on Thursday, February 25, 2021 Read more about Iovance Biotherapeutics to Host Fourth Quarter and Full Year 2020 Financial Results Conference Call and Webcast on Thursday, February 25, 2021 Iovance Biotherapeutics to Present at Upcoming Healthcare Conferences Read more about Iovance Biotherapeutics to Present at Upcoming Healthcare Conferences Iovance Biotherapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference on January 14, 2021 Read more about Iovance Biotherapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference on January 14, 2021 Iovance Biotherapeutics Appoints Jean-Marc Bellemin as Chief Financial Officer Read more about Iovance Biotherapeutics Appoints Jean-Marc Bellemin as Chief Financial Officer Iovance Biotherapeutics to Present at Upcoming Conferences in December Read more about Iovance Biotherapeutics to Present at Upcoming Conferences in December Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last » Subscribe to
Iovance Biotherapeutics Announces Clinical Data Updates for Lifileucel in Advanced Melanoma During American Association for Cancer Research (AACR) 2021 Annual Meeting Read more about Iovance Biotherapeutics Announces Clinical Data Updates for Lifileucel in Advanced Melanoma During American Association for Cancer Research (AACR) 2021 Annual Meeting
Iovance Biotherapeutics Appoints Igor Bilinsky as Chief Operating Officer Read more about Iovance Biotherapeutics Appoints Igor Bilinsky as Chief Operating Officer
Iovance Biotherapeutics to Present Updated Clinical Data for Tumor Infiltrating Lymphocyte (TIL) Therapy Lifileucel in Advanced Melanoma at American Association for Cancer Research (AACR) 2021 Annual Meeting Read more about Iovance Biotherapeutics to Present Updated Clinical Data for Tumor Infiltrating Lymphocyte (TIL) Therapy Lifileucel in Advanced Melanoma at American Association for Cancer Research (AACR) 2021 Annual Meeting
Iovance Biotherapeutics to Present at Upcoming Healthcare Conferences Read more about Iovance Biotherapeutics to Present at Upcoming Healthcare Conferences
Iovance Biotherapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Corporate Updates Read more about Iovance Biotherapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Corporate Updates
Iovance Biotherapeutics to Host Fourth Quarter and Full Year 2020 Financial Results Conference Call and Webcast on Thursday, February 25, 2021 Read more about Iovance Biotherapeutics to Host Fourth Quarter and Full Year 2020 Financial Results Conference Call and Webcast on Thursday, February 25, 2021
Iovance Biotherapeutics to Present at Upcoming Healthcare Conferences Read more about Iovance Biotherapeutics to Present at Upcoming Healthcare Conferences
Iovance Biotherapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference on January 14, 2021 Read more about Iovance Biotherapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference on January 14, 2021
Iovance Biotherapeutics Appoints Jean-Marc Bellemin as Chief Financial Officer Read more about Iovance Biotherapeutics Appoints Jean-Marc Bellemin as Chief Financial Officer
Iovance Biotherapeutics to Present at Upcoming Conferences in December Read more about Iovance Biotherapeutics to Present at Upcoming Conferences in December
